Genentech
HERCEPTIN HYLECTA
Manufacturer:
Genentech
Name:
HERCEPTIN HYLECTA
HCPCS Code Descriptor:
Injection, trastuzumab, 10 mg and hyaluronidase-oysk
Category:
J Code
HCPCS:
J9356
NDC(s):
50242-0077-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
HERCEPTIN HYLECTA is an Oncology drug manufactured by Genentech and administered via the Subcutaneous route of administration. The J Code: J9356 is aligned to the drug HERCEPTIN HYLECTA.
Access Pricing and More By Registering
HCPCS Added Date:
7/1/19
HCPCS Effective Date:
7/1/19
HCPCS Short Description:
Inj. herceptin hylecta, 10mg
Billing and Coding Guide:
https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/Herceptin-Hylecta-Billing-Coding-for-Breast-Cancer.pdf
Patient Assistance:
https://www.gene.com/patients/patient-foundation